Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

BACKGROUND: Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may inc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Onland, Wes, Offringa, Martin, Cools, Filip, De Jaegere, Anne P, Rademaker, Karin, Blom, Henry, Cavatorta, Eric, Debeer, Anne, Dijk, Peter H, van Heijst, Arno F, Kramer, Boris W, Kroon, Andre A, Mohns, Thilo, van Straaten, Henrica L, te Pas, Arjan B, Theyskens, Claire, van Weissenbruch, Mirjam M, van Kaam, Anton H
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245429/
https://ncbi.nlm.nih.gov/pubmed/22070744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-11-102
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi